This Japanese-based company, SBC Medical Group Holdings Inc. (NASDAQ: SBC) is now making waves in the aesthetic healthcare market, offering a promising opportunity for investors in 2025.

After its merger with Pono Capital Two, Inc., SBC is now listed on the Nasdaq Global Market under the ticker symbol “SBC.” This listing not only gives the company better access to international capital but also paves the way for its ambitious growth plans in the United States and Southeast Asia.

Since the merger, SBC has been quick to build on its elevated status. One of its major moves includes acquiring Aesthetic Healthcare Holdings Pte. Ltd. (AHH), a leading operator of aesthetic treatment clinics in Singapore.

This acquisition adds 21 clinics under four established brands to SBC’s portfolio, making Singapore a central hub for its Asian operations. This strategic expansion positions SBC to tap into the growing demand for aesthetic medical services in the region.

SBC has also partnered with Japan’s MEDIROM Healthcare Technologies Inc., known for its extensive network of relaxation studios. This collaboration aims to blend SBC’s expertise in aesthetic healthcare with MEDIROM’s wellness services, offering comprehensive health and beauty solutions to a combined customer base of over 4 million people. This partnership not only boosts SBC’s market reach but also enhances its reputation in the industry.

On the financial front, SBC is showing impressive growth. For the third quarter of 2024, the company reported $53 million in revenue, a 12% increase compared to the same period in 2023. In the first nine months of the year, revenue reached $160 million, up 23% from the previous year.

Net income also grew significantly, with $40 million recorded for the nine-month period, a 60% jump from 2023. These figures highlight SBC’s ability to grow its business and deliver strong results.

SBC’s expanding network of clinics — 224 as of September 2024 — shows its scalable business model is working. Each new clinic strengthens its market position and adds to its revenue, making SBC a strong player in the aesthetic healthcare industry.

For investors, SBC offers a compelling story of growth and innovation. Its Nasdaq listing increases visibility and makes it easier to invest in the company. The recent acquisitions and partnerships highlight SBC’s commitment to expansion and creating value for shareholders. Coupled with its solid financial performance, SBC is well-positioned for long-term success.

As more people focus on wellness and aesthetics, SBC Medical Group is leading the way with its cutting-edge services. For investors, this is a chance to be part of a thriving market with a company that’s delivering on its promises.

With its recent achievements and ambitious plans, SBC Medical Group is definitely a worthwhile stock to be taking up a space in my portfolio for 2025.